New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Citius Pharmaceuticals, Inc.
CTXR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

14M

Biotechnology

Next Earning date - 13 May 2025

14M

Biotechnology

Next Earning date - 13 May 2025

1.58USD

Shape-0.21 ( -11.73%)
sun-fogPre-market 1.69$arrow-right-up0.04 (2.73%)
Market Closed (as of Mar 10, 20:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-27%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

94%

Quote Panel

Shape
Updated March 11, 2025
1W -7.06 % 1M -39.69 % 3M -44.76 % 1Y -90.90 %

Key Metrics

Shape
  • Market Cap

    13.58M


  • Shares Outstanding

    8.59M


  • Share in Float

    8.10M


  • Dividende

    0


  • Earning Date

    13 May 2025


  • Price Target

    1.58


  • Average Volume

    155920


  • Beta

    1.179


  • Range

    1.47-26.75


  • Industry

    Biotechnology


  • Website

    https://www.citiuspharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CTXR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$15M

ShapeNaN%

2025-Revenue

$1.35

Shape2502%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Not converted

2024-12-30

Now: Buy

EF Hutton

initialise

Previous: Not converted

2024-07-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-1.75
vs -1.25

Q2.23

arrow
arrow

N/A

-1.50
vs -1.50

Q3.23

arrow
arrow

N/A

-1.75
vs -1.25

Q4.23

arrow
arrow

N/A

-1.50
vs -1.00

Q1.24

arrow
arrow

N/A

-1.25
vs -1.75

Q2.24

arrow
arrow

N/A

-1.50
vs -1.50

Q3.24

arrow
arrow

N/A

-0.06
vs -1.75

Q4.24

arrow
arrow

N/A

-1.30
vs -1.50

Q1.25

arrow
arrow

+204%

1.3
vs -1.25

Q2.25

arrow
arrow

N/A

-0.52
vs -1.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

155.9K  vs NA

Q4.24

arrow
arrow

NA

NA  vs NA

Q1.25

arrow
arrow

NA

5.3M  vs NA

Q2.25

arrow
arrow

NA

3.8M  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-12%

-0.12
vs -0.04

Q2.23

arrow
arrow

-9%

-0.09
vs -0.12

Q3.23

arrow
arrow

-11%

-0.11
vs -0.09

Q4.23

arrow
arrow

-11%

-0.11
vs -0.11

Q1.24

arrow
arrow

-11%

-0.11
vs -0.11

Q2.24

arrow
arrow

-12%

-0.12
vs -0.11

Q3.24

arrow
arrow

-15%

-0.15
vs -0.12

Q4.24

arrow
arrow

-15%

-0.15
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

59

59
vs 55

7%

Q2.23

arrow
arrow

78

78
vs 59

32%

Q3.23

arrow
arrow

76

76
vs 78

-3%

Q4.23

arrow
arrow

76

76
vs 76

NA

Q1.24

arrow
arrow

72

72
vs 76

-5%

Q2.24

arrow
arrow

72

72
vs 72

NA

Q3.24

arrow
arrow

59

59
vs 72

-18%

Q4.24

arrow
arrow

3

3
vs 59

-95%

Earnings Growth

Latest News